Senores (SENORES) | Stock Overview & Key Data
Senores Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,311.00 on June 15, 2026
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Senores
SENORES
|
41.04B Small-cap | 27.43% | 22.17% | 72.40% | 57.40% | 55.27% | 131.62% | 125.07% | 125.07% | 125.07% | 125.07% | 125.07% |
|
GlaxoSmithKline
GLAXO
|
422.67B Large-cap | -3.19% | -13.28% | -11.99% | -17.96% | -13.88% | -35.63% | 50.14% | 45.44% | -39.87% | -9.78% | 324.98% |
|
Pfizer
PFIZER
|
218.82B Large-cap | -0.22% | -8.81% | -4.87% | -9.94% | -8.09% | -23.35% | 16.94% | -16.55% | 139.64% | 232.33% | 479.18% |
|
Sms Pharmaceuticals
SMSPHARMA
|
37.15B Small-cap | 2.49% | -5.59% | 3.24% | 16.68% | 20.59% | 54.90% | 314.99% | 124.70% | 340.29% | 1,909.70% | 1,070.48% |
|
NGL Fine-Chem
NGLFINE
|
13.81B Small-cap | 17.19% | 32.28% | 42.63% | 133.76% | 122.63% | 190.36% | 86.41% | 63.13% | 63.13% | 63.13% | 63.13% |
|
TTK Healthcare
TTKHLTCARE
|
13.01B Small-cap | -2.04% | -2.14% | 6.84% | -16.44% | -14.48% | -30.05% | -29.39% | 43.44% | -3.20% | 117.54% | 214.14% |
Ownership & Short Interest
Calculate Your Senores Investment Returns
Long-Term Investment Performance Analysis
Senores stock price in Dec 2024 was ₹573.15, A ₹1,000.00 lump sum investment in Senores made 1 years ago would be worth approximately ₹2,238.86 today, representing a strong return of 123.89%. This translates to an annualized return (CAGR) of 73.91%.
1 Year 5 Months Investment Scenario (Dec 2024 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is SENORES's 52-week high and low?
- In the last 52 weeks, Senores reached a high of ₹1,311.00 (on June 15, 2026) and a low of ₹513.00 (on June 19, 2025).
- What is the market cap and P/E ratio for SENORES?
- Curious about Senores's size and valuation? Its market capitalization stands at 41.04B. When it comes to valuation, the P/E ratio (trailing twelve months) is 35.50, and the forward P/E (looking ahead) is 29.38.
- Does SENORES pay dividends? If so, what's the yield?
- As for dividends, Senores isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Senores's main competitors or similar companies to consider before investing?
When looking at Senores, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return GlaxoSmithKline
GLAXO422.67B Healthcare Drug Manufacturers - General -35.63% 50.14% Pfizer
PFIZER218.82B Healthcare Drug Manufacturers - General -23.35% 16.94% Sms Pharmaceuticals
SMSPHARMA37.15B Healthcare Drug Manufacturers - General 54.90% 314.99% NGL Fine-Chem
NGLFINE13.81B Healthcare Drug Manufacturers - General 190.36% 86.41% TTK Healthcare
TTKHLTCARE13.01B Healthcare Drug Manufacturers - General -30.05% -29.39% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Senores Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Senores's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.21%, the Debt to Equity ratio from the most recent quarter is 28.90, and its Gross Profit Margin stands at 59.34%.
- What is the recent revenue and earnings growth for SENORES?
- Looking at Senores's growth, its revenue over the trailing twelve months (TTM) was INR6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 60.00%, and quarterly earnings saw a YoY growth of 84.30%.
- How much of SENORES stock is held by insiders and institutions?
- Wondering who owns Senores stock? Company insiders (like executives and directors) hold about 55.57% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 7.74%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.